OTC de-listings
November 3, 2015
The Health Department has
finalised its list of over-the=counter
items recommended for
de-listing or amendment on the
Pharmaceutical Benefits Scheme
effective from 01 Jan 2016.
The deletions will result in all
forms of four items being deleted
from the PBS: aluminium hydroxide
with magnesium trisilicate and
magnesium hydroxide; ferrous
fumarate; ferrous furmarate with
folic acid; and chloramphenicol.
Other items affected include
aspirin, bisacodyl, oral electrolyte
replacement, folic acid, glycerol,
hydrocortisone, nystatin,
hydroxocabalamin and paracetamol.
Some items delisted will be
transferred to the Repatriation
Schedule of Pharmaceutical
Benefits while others will stay
on the PBS but only for patients
identifying as Aboriginal or Torres
Strait Islanders - www.pbs.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 03 Nov 15To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Nov 15